Oryzon Genomics to Present at the 19th Annual BIO CEO & Investor Conference 2017

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Dr. Carlos Buesa, Oryzon’s Chief Executive Officer, is scheduled to present at the 2017 BIO CEO & Investor Conference being held February 13-14, 2017 at the Waldorf Astoria Hotel in New York City.

Dr. Buesa’s presentation will take place on Monday, February 13th 2017 at 9:30am EST in the Conrad room during the conference's CNS/Neurological Track.

Click here to see the full Press Release